InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Sessa Capital (Master), L.P.. Insider active across 2 companies, notably Provention Bio, Inc.. Cumulatively, 7 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €26.1m. History available since 18 January 2023. The latest transaction was disclosed on 29 September 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Sessa Capital (Master), L.P. is a declarant linked to Provention Bio, Inc. and to SAB Biotherapeutics, Inc., where the listed role is Director. Its 7 filings cover the period from 2023-01-20 to 2025-10-01 in the sampled filings, with 0 EUR of buys and 26127300 EUR of sells, and the most common transaction nature is option exercise.